Page last updated: 2024-11-08

triiodothyronine and Fabry Disease

triiodothyronine has been researched along with Fabry Disease in 1 studies

Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.

Fabry Disease: An X-linked inherited metabolic disease caused by a deficiency of lysosomal ALPHA-GALACTOSIDASE A. It is characterized by intralysosomal accumulation of globotriaosylceramide and other GLYCOSPHINGOLIPIDS in blood vessels throughout the body leading to multi-system complications including renal, cardiac, cerebrovascular, and skin disorders.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Faggiano, A1
Severino, R1
Ramundo, V1
Russo, R1
Vuolo, L1
Del Prete, M1
Marciello, F1
Lombardi, G1
Cianciaruso, B1
Colao, A1
Pisani, A1

Other Studies

1 other study available for triiodothyronine and Fabry Disease

ArticleYear
Thyroid function in Fabry disease before and after enzyme replacement therapy.
    Minerva endocrinologica, 2011, Volume: 36, Issue:1

    Topics: Adult; Algorithms; alpha-Galactosidase; Biomarkers; Case-Control Studies; Enzyme Replacement Therapy

2011